Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18156645 | 0.88 | FASN (0.39) | FASN | |
| SCHEMBL21567712 | 0.88 | CYP2C9 (0.37) | — | |
| SCHEMBL12929166 | 0.87 | FASN (0.42) | FASN | |
| SCHEMBL19679585 | 0.84 | FASN (0.39) | FASN | |
| SCHEMBL17402091 | 0.84 | FASN (0.40) | FASN | |
| SCHEMBL16572425 | 0.84 | FASN (0.42) | FASN | |
| SCHEMBL15744309 | 0.84 | FASN (0.42) | FASN | |
| SCHEMBL15745168 | 0.84 | FASN (0.42) | FASN | |
| SCHEMBL15744514 | 0.83 | FASN (0.42) | FASN | |
| SCHEMBL19679589 | 0.83 | FASN (0.34) | FASN |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11046888-B2 | Difluoromethoxy-bridge liquid crystal compound containing methyl-substituted 2,3-difluorophenyl and crystal composition | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2021-06-29 | — | — | US | disclosed |
| US-20190345388-A1 | DIFLUOROMETHOXY-BRIDGE LIQUID CRYSTAL COMPOUND CONTAINING METHYL-SUBSTITUTED 2,3-DIFLUOROPHENYL AND CRYSTAL COMPOSITION | SHIJIAZHUANG CHENGZHI YONGHUA DISPLAY MATERIAL CO., LTD. (CN) | 2019-11-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190345388-A1 | DIFLUOROMETHOXY-BRIDGE LIQUID CRYSTAL COMPOUND CONTAINING METHYL-SUBSTITUTED 2,3-DIFLUOROPHENYL AND CRYSTAL COMPOSITION | CCDC22, YTHDC1, DLK1 | FASN 3792/4885 |
| US-11046888-B2 | Difluoromethoxy-bridge liquid crystal compound containing methyl-substituted 2,3-difluorophenyl and crystal composition | CCDC22, YTHDC1, DLK1 | FASN 3792/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.